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ABSTRACT 
Swine mycoplasmas are acknowledged for their potential to contribute to several swine 
disease complexes.  In addition, mycoplasma-associated arthritis has recently been 
recognized as a re-emergent issue in the swine industry.  Reports from Veterinary Diagnostic 
Laboratories suggest an increasing incidence of cases occurring in the major regions of swine 
production in the U.S.  Although previous studies reproduced polyarthritis by inoculating 
pigs with either Mycoplasma hyosynoviae or M. hyorhinis, there is a lack of information 
regarding the epidemiology of these microorganisms within swine populations.  In addition, 
although new diagnostic tools have become available, information regarding the application 
and performance of these assays is lacking.  
Therefore, a major objective of the work described in this thesis was to review and to provide 
new information regarding the use of diagnostic methods in the detection of M. hyosynoviae 
and M. hyorhinis. In order to evaluate the performance of a new real-time polymerase chain 
reaction (RT-PCR), a comparison of various DNA extraction methods using different clinical 
specimens was conducted in the laboratory.  Thereafter, a field study was carried using RT-
PCR- and antibody-based assays to monitor the infection dynamics of these microorganisms 
in a wean-to-finish population.   
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THESIS ORGANIZATION 
The thesis begins with a review of the literature concerning mycoplasma-associated arthritis.  
In particular, the review focused on M. hyosynoviae and M. hyorhinis, including 
pathogenesis, clinical signs, animal selection, diagnostic sample collection, and diagnostic 
assays to be used for mycoplasma-associated arthritis cases.  The review was published in the 
Journal of Swine Health and Production. 
In Chapter 2, diagnostic methods were evaluated by comparing the rate of detection of M.  
hyosynoviae or M. hyorhinis by real-time polymerase chain reaction (RT-PCR) in clinical 
specimens, i.e., oral fluids (n = 60), tonsil scraping fluids (n = 49), nasal swab fluids (n = 81), 
and serum (n = 150), collected from pigs selected from 5 commercial finisher sites.  Nucleic 
acid extraction methods compared in the study included high volume (HV) and low volume 
(LV) extraction using magnetic beads and a spin column-based protocol (SC).   
In Chapter 3, the dynamics of M. hyosynoviae and M. hyorhinis infections were followed 
over time in a wean-to-finish population using RT-PCR- and antibody-based assays.   
The thesis ends with General Conclusions discussing the major findings of the research and 
the author's observations and opinions regarding the application of these new techniques in 
the diagnosis and field surveillance of M hyosynoviae and M. hyorhinis. 
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CHAPTER 1.  MYCOPLASMA-ASSOCIATED ARTHRITIS: CRITICAL POINTS 
FOR DIAGNOSIS 
Published in the Journal of Swine Health and Production 
Joao Carlos Gomes Neto; Phillip C. Gauger; Erin L. Strait; Neil Boyes; Darin M. Madson; 
Kent J. Schwartz 
Abstract 
Mycoplasma hyosynoviae and Mycoplasma hyorhinis are known causative agents of arthritis 
in post-weaned swine.  Data from the Iowa State University Veterinary Diagnostic 
Laboratory shows that diagnosis of M. hyosynoviae- and M. hyorhinis-associated arthritis has 
increased in swine in the Midwest United States.  This diagnostic note summarizes disease 
characteristics of both pathogens and describes appropriate procedures to diagnose 
mycoplasma-associated arthritis.  An accurate diagnosis is critical to establishing effective 
treatment and prevention measures in affected herds. 
Keywords: swine, arthritis, Mycoplasma hyorhinis, Mycoplasma hyosynoviae. 
 
Introduction 
Arthritis is defined as inflammation of the intra-articular tissue of one or more joints.  It is 
characterized by an increased volume of intra-articular fluid with specific features that vary 
depending on the cause.  Features that may have diagnostic significance include color, 
turbidity, hemorrhage, or exudate.  In addition, arthritis may be classified according to the 
cause, the duration (i.e., acute, chronic), or the components of the exudate, i.e., serous, 
fibrinous, purulent, macrophagic, lymphoplasmacytic (Weisbrode et al., 2001). 
Infectious arthritis in swine is commonly associated with bacteria.  Pathogens isolated from 
arthritic joints may include Erysipelothrix rhusiopathiae, Streptococcus suis, Haemophilus 
parasuis, Actinobacillus suis, Arcanobacterium pyogenes, Staphylococcus species, 
Salmonella cholearaesuis, Mycoplasma hyorhinis, and Mycoplasma hyosynoviae (Friis et al., 
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1992a; Hariharan et al., 1992; Magnusson et al., 1998; Turner, 1982).  Infectious arthritis is 
an increasing concern to swine producers as it may contribute to compromised animal 
welfare and decrease profitability of the operation.  Despite concerns and a long history of 
recognition, specific information is often lacking regarding the pathogenesis, epidemiology, 
and control of infectious arthritis in modern swine-production systems. 
The Iowa State University Veterinary Diagnostic Laboratory (ISU-VDL) diagnosed 431 
cases of lameness between 2003 and 2010.  Overall, 69% (298 of 431) of the clinical cases 
had evidence of infectious arthritis.  Mycoplasma species accounted for an average of 17% of 
arthritis cases over all 8 years, with an increasing frequency in recent years, up to 37% (41 of 
111) in 2010 (Figure 1).  Mycoplasma hyorhinis was diagnosed more frequently in animal ≤ 
10 weeks of age.  Conversely, M. hyosynoviae was diagnosed more often in animals > 10 
weeks of age (Figure 2).  However, due to the inherent bias of diagnostic data and lack of 
random sampling, it is difficult to correlate these numbers to the actual disease prevalence in 
the field. 
In response to the increasing number of mycoplasma-associated arthritis cases diagnosed at 
the ISU-VDL, this article will describe disease characteristics as well as proper sampling and 
diagnostic tests necessary to establish a diagnosis of M. hyorhinis- and M. hyosynoviae-
associated arthritis in swine. 
 
Pathogenesis 
Mycoplasma hyorhinis colonizes the upper respiratory tract of pigs, and may be isolated from 
swine lungs with or without pneumonia (Kobisch et al., 1996; Lin et al., 2006).  However, 
systemic disease is more commonly diagnosed after weaning (Thacker, 2006).  The process 
of systemic dissemination remains unknown, but affinity for serosal surfaces may lead to 
acute inflammation of the serosa of body cavities and synovium (membrane lining the joint 
cavity).  If not effectively mitigated by the immune response or medication, infections at 
those sites may become chronic, resulting in compromised growth and performance 
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(Browning et al., 2010).  Serofibrinous pleuritis, pericarditis, and peritonitis are typical 
lesions that may generate fibrous adhesions in chronic stages (Kobisch et al., 1996; 
Magnusson et al., 1998; Thacker, 2006). 
Mycoplasma hyosynoviae may cause arthritis in pigs approximately 2 to 3 weeks post 
exposure (Hagdorn-Olsen et al., 1999a).  Tonsils are the primary site of infection, which may 
persist to the adult age and occasionally cause systemic disease at that time (Hagdorn-Olsen 
et al., 1999a; Hagdorn-Olsen et al., 1999b; Kobisch et al., 1996; Thacker, 2006).  There is an 
incubation period of approximately 3 to 10 days that may often follow stress, such as 
movement or vaccination (Hagdorn-Olsen et al., 1999a; Hagdorn-Olsen et al., 1999b; 
Thacker, 2006).  The acute phase of infection lasts approximately 2 weeks, during which 
time the pathogen may spread to the joints and various tissues (eg, spleen, lung) throughout 
the body by a hematogenous route (Hagdorn-Olsen et al., 1999a; Hagdorn-Olsen et al., 
1999b).  
Many factors may influence mycoplasma-associated arthritis disease expression, including 
maternal or herd immunity, strain virulence, management practices or biosecurity, breed, and 
environment (Thacker, 2006).  However, it is currently unknown how each of these factors 
may contribute to disease pathogenesis. 
 
Clinical Signs 
Mycoplasma hyorhinis may be associated with polyserositis and polyarthritis, generally 
occurring in 3-to 10-week-old pigs,
 
although occasionally it may occur in older animals 
(Magnusson et al., 1998; Thacker, 2006).  Clinical signs typically occur 3 to 10 days after 
exposure and continue for approximately 10 to 14 days, depending on the severity of disease 
and presence of co-infections.  Pigs appear unthrifty and lethargic and may demonstrate 
reluctance to move, lameness, and swollen joints.  In addition, conjunctivitis and otitis have 
been associated with M. hyorhinis infection (Friis et al., 2002b; Kobisch et al., 1996; Morita 
et al., 1995; Thacker, 2006). 
4 
 
 
Mycoplasma hyosynoviae lameness generally occurs in 3- to 5-month-old pigs, appearing 
acutely in one or more legs (Kobisch et al., 1996; Nielsen et al., 2001a).  Clinical signs that 
may occur in a portion of or all affected animals include lameness, stiffness, swollen joints, 
pain or discomfort, and reluctance to stand (Nielsen et al., 2001a; Ross et al., 1971).  Clinical 
signs may persist for 3 to 10 days, after which lameness gradually decreases in severity.  
Many animals recover without treatment; however, clinical signs may persist, especially 
when co-infections or joints lesions such as osteochondritis dissecans are present.  Swollen 
joints may or may not be observed in lame pigs with infectious arthritis.  However, 
discomfort during ambulation and reluctance to stand can be frequently observed in the 
majority of affected pigs and suggests further evaluation. 
 
Animal and Sample Selection and Procedures 
Nursery, grower, or finisher pigs demonstrating lameness, swollen joints, reluctance to stand, 
shifting hind-limb lameness, or a painful, uncomfortable gait may be selected for sampling.  
Acutely affected pigs without prior antibiotic treatment are preferred for diagnostic testing.  
Chronically affected pigs that have demonstrated prolonged lameness, joint abscesses, 
recumbency, and emaciation often have other-co-infections that compromise the accuracy of 
diagnosis, and these animals should be avoided.  Selected animals should be humanely 
euthanized immediately prior to sampling.  Pigs that have already died should be avoided due 
to potential chronicity, death due to a noninfectious process, lack of a proper ante-mortem 
examination, or combinations of these. 
Determining the correct sampling procedures to use will depend on the objectives of the 
investigation.  Basically, two different outcomes may be pursued.  The first is that of a 
definitive diagnosis for the clinical disease present in a particular situation.  The second may 
be more epidemiological, that is, detection of the pathogen within a specific population to 
determine prevalence, incidence, or age of colonization. 
Although M. hyosynoviae and M. hyorhinis may be present as commensal organisms in the 
upper respiratory tract of unaffected animals; confirming mycoplasma-associated arthritis 
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requires detection of the pathogen in affected joints and characteristic microscopic lesions in 
synovial tissue (Hagdor-Olsen et al., 1999b; Thacker, 2006). 
Following clinical evaluation, necropsy should include an evaluation of all joints and body 
systems.  Gross observation of serofibrinous to fibrinopurulent polyserositis and arthritis are 
suggestive of M. hyorhinis infection; however, similar lesions may be caused by infection 
with Haemophilus parasuis and Streptococcus suis (Kobisch et al., 1996).  Mycoplasma 
hyosynoviae-affected joints tend to have large amounts of yellow or brown viscous fluid of a 
serofibrinous or serosanguineous nature.  The synovial membrane may appear dark in color, 
edematous, proliferative, or hyperemic (Kobisch et al., 1996; Nielsen et al., 2001a). 
Synovial fluid from elbow, stifle, hock, and shoulder should be collected using a sterile 
syringe and appropriately sized needle (eg, selected based on age) after removing the skin 
and sterilizing the region with a small propane flame to decrease bacterial contamination 
(Figure 3).  Affected whole legs may be submitted intact to the diagnostic laboratory as an 
alternative to tissue samples and joint fluid. 
Lung tissues should be submitted when fibrinous pleuritis is present and M. hyorhinis 
infection suspected.  Pericardial, thoracic, and peritoneal fluid may also be submitted if 
excess effusions or polyserositis are present.  Fresh and fixed heart, as well as other 
abdominal tissues such as liver and spleen, should be submitted in cases where polyserositis 
is prominent. 
An alternative sampling option when insufficient synovial fluid is available may include 
multiple swabs aseptically collected after carefully opening the joint (Figure 4).  Multiple 
pieces of synovium should be collected in 10% formalin and included for microscopic 
evaluation.  The presence of characteristic microscopic lesions in synovium, in addition to 
pathogen detection, is required for a definitive diagnosis. 
Synovial fluid from live animals can be collected from swollen joints using a sterile syringe 
and needle after a surgical preparation of the affected area.  An advantage of this procedure is 
that euthanasia can be avoided; however, this technique causes discomfort to the animal and 
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usually requires sedation for proper sampling. 
Cross-sectional samples derived from weaning- to finishing-age pigs may be used to 
determine the prevalence of Mycoplasma infection within a population, or prevalence may be 
determined longitudinally by following a specific group of animals over time.  Cross-
sectional studies can be used to determine the number of positive animals over time in a 
specific population.  A disadvantage of this method is that one group of animals may not 
represent the prevalence of Mycoplasma infection in the entire herd.  Therefore, horizontal or 
serial studies may be more appropriate to determine the approximate time pigs become 
colonized with M. hyosynoviae or M. hyorhinis or the prevalence of positive animals over 
time.  However, either method may require evaluation of multiple groups depending on the 
diagnostic question and the herd situation (eg, herds that have a stable parity flow may 
require fewer groups to establish a pattern). 
Nasal swabs and tonsil scrapings should be collected individually and not pooled for sample 
analysis.  Mycoplasma hyorhinis may be detected in nasal swabs; however, tonsil scrapings 
are more appropriate for detecting M. hyosynoviae. 
 
Submission of Samples 
Sample submission to a diagnostic laboratory should include a complete and thorough history 
and clinical evaluation.  A complete history should include a description and the duration of 
clinical signs, age and total number of affected animals, mortality, and differential diagnosis 
where applicable. 
Synovial fluid or effusions should be transferred to polystyrene tubes prior to submission, 
which helps avoid leakage, cross-contamination, and damage during shipping.  Synovial 
swabs and fluids, tissues samples, effusions, and intact joints or legs should be submitted on 
ice and shipped within 24 hours of collection to a diagnostic laboratory.  Swabs should be in 
transport medium (eg, Amies medium) to prevent dehydration.  Tissues submitted in 10% 
formalin should be properly identified and packaged appropriately to minimize the 
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possibility of leakage.  If appropriate conditions and instruments for sampling are not 
available, submission of affected whole legs or a live, acutely affected animal is preferred.  
All samples submitted to a diagnostic laboratory should be fresh and kept cool prior to and 
during shipment. 
 
Diagnostic Tests 
Real-time polymerase chain reaction (PCR) is the most sensitive assay available to detect 
Mycoplama species.  Real-time PCR assays have been developed for both M. hyorhinis and 
M. hyosynoviae and may be conducted directly on clinical specimens (such as joint fluid), 
joint swabs, nasal swabs, or tonsil scrapings when applicable.  Bacterial culture is available 
upon request and is necessary if further evaluation of an isolate is warranted, such as 
antibiotic-resistance profiles.  However, bacterial cultures are time consuming and can be 
overgrown by other bacterial species.  Mycoplasma species require specialized medium for 
growth; therefore, a specific request for Mycoplasma culture is required. 
Microscopic lesions characteristic of mycoplasma infection are necessary to confirm a 
diagnosis of mycoplasma-associated arthritis.  Mycoplasma hyosynoviae microscopic lesions 
may include hyperplasia of the synovium, moderate synovial villous hypertrophy, edema, 
and mononuclear cell infiltration with mild fibrosis of the capsule (Kobisch et al., 1996; 
Nielsen et al., 2001a).  Mycoplasma hyorhinis typically induces a mixture of mononuclear 
and polymorphonuclear cells in serosal and synovial membranes, which may lead to erosion 
of cartilage and pannus formation in chronically affected joints (Figure 5 and 6) (Kobisch et 
al., 1996; Thacker, 2006). 
Maternal antibodies against Mycoplasma species may be present for some time after weaning 
in positive herds, although the duration of maternal immunity has not been widely studied.  
Antibody detection in post-weaned animals may help determine the exposure status of that 
particular group when followed over time.  Conversely, it is not uncommon to find PCR-
positive animals with no detectable antibody titers (“JCGN, personal observation”).  In pigs 
experimentally infected with M. hyosynoviae, antibody titers persisted for as long as 6 
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months post inoculation (Zimmerman et al., 1982).  Mycoplasma infection demonstrated in 
tonsils was correlated with a significantly higher antibody response in carrier pigs.  In 
addition, slaughter pigs with higher antibody titers were more likely to demonstrate 
Mycoplasma in tonsils (Nielsen et al., 2005b). 
 
Implications 
To diagnose mycoplasma-associated arthritis, remember: 
 An accurate and complete history is critical to a definitive diagnosis of lameness in 
swine. 
 Select untreated animals in the acute stage of lameness for submission to a veterinary 
diagnostic laboratory. 
 Joint fluid, joint swabs, synovium in 10% formalin, or whole affected legs may be 
submitted to a veterinary diagnostic laboratory for lameness diagnostics. 
 Ancillary tests, such as PCR or culture of joint fluid or swabs, are useful to confirm 
the presence of Mycoplasma species. 
 A complete diagnosis of mycoplasma-associated arthritis requires the presence of 
microscopic lesions and identification of the organism in affected tissue. 
 Communicate with the veterinary diagnostic laboratory if there are any questions. 
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Figure 1.  Frequency of diagnosis of Mycoplasma hyosynoviae and Mycoplasma hyorhinis in 
cases of swine lameness submitted to the Iowa State University Veterinary Diagnostic 
Laboratory (Ames, Iowa) between 2003 and 2010.  
12 
 
 
 
Figure 2.  Frequency of Mycoplasma hyosynoviae and Mycoplasma hyorhinis cases 
diagnosed by age from the total number of cases of swine lameness submitted to the Iowa 
State University Veterinary Diagnostic Laboratory (Ames, Iowa) between 2003 and 2010. 
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Figure 3.  Collecting joint fluid from a 6-week-old pig demonstrating lameness prior to 
diagnostic testing.  Photo courtesy of Dr. Philip Gauger, Iowa State University Veterinary 
Diagnostic Laboratory, Ames, Iowa. 
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Figure 4.  Swabbing the intra-articular cavity for diagnostic testing.  Photo courtesy of Dr. 
Philip Gauger, Iowa State University Veterinary Diagnostic Laboratory, Ames, Iowa. 
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Figure 5.  Photomicrograph from a 12-week-old pig demonstrating lameness in which 
Mycoplasma hyosynoviae was detected by real-time polymerase chain reaction (PCR) in joint 
fluids.  Chronic proliferative synovitis with mononuclear inflammation of the synovial 
membrane and hyperplasia and hypertrophy of synoviocytes (arrows) (H&E stain, original 
magnification 100x).  Photo courtesy of Dr. Darin Madson, Iowa State University Veterinary 
Diagnostic Laboratory, Ames, Iowa. 
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Figure 6.  Photomicrograph from a 6-week-old pig exhibiting swollen joints in which 
Mycoplasma hyorhinis was detected by real-time PCR in joint fluids.  Fibrinosuppurative 
inflammation of the synovial membrane with a mixture of mononuclear and 
polymorphonuclear cells in the subsynovial connective tissues (*) (H&E stain, original 
magnification 100x).  Arrows indicate hyperplasia and hypertrophy of synoviocytes.  Photo 
courtesy of Dr. Darin Madson, Iowa State University Veterinary Diagnostic Laboratory, 
Ames, Iowa. 
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Abstract 
Three methods of DNA extraction were evaluated by comparing the rate of detection of 
Mycoplasma hyosynoviae or M. hyorhinis by real-time polymerase chain reaction (RT-PCR) 
in clinical specimens, i.e., oral fluids (n = 60), tonsil scraping fluids (n = 49), nasal swab 
fluids (n = 81), and serum (n = 150), collected from pigs selected from 5 commercial finisher 
sites.  Nucleic acid extraction methods included high volume (HV) and low volume (LV) 
extraction using magnetic beads and a spin column-based protocol (SC).  RT-PCR was 
performed in duplicate, and results were considered negative if cycle threshold (Ct) values 
were > 44.  Depending on the extraction protocol, M. hyosynoviae DNA was detected in at 
least 58.3%, 9.9%, and 75.5% of pen-based oral fluids, nasal swab fluids, and tonsil scraping 
fluids, respectively.  M. hyorhinis DNA was detected in at least 70% of all pen-based oral 
fluids and in 96.3% and 97.9% of nasal swab fluids and tonsil scraping fluids, respectively.  
No statistically significant differences (P > 0.05) in the rate of detection were observed in 
comparisons of DNA extraction protocols by sample type, although differences in the 
absolute number of positives were observed for both sample type and extraction protocol.  
An evaluation of extraction protocol (magnetic beads vs. spin column) across all sample 
types revealed more positive results associated with spin column extraction.  Overall, these 
data suggest that tonsillar scrapings are preferable to nasal swab fluid for screening 
individual animals, whereas oral fluids may be useful for population surveillance.   
Key words: Mycoplasma hyorhinis, Mycoplasma hyosynoviae, real-time PCR, sample types. 
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Introduction 
Although recognized as ubiquitous in swine populations since the 1970’s, Mycoplasma 
hyosynoviae and M. hyorhinis have also been considered causal agents of arthritis in 
pigs.
1,2,3,4, 5,6
  Mycoplasma hyorhinis colonizes the upper respiratory tract of pigs and is 
commonly associated with polyarthritis and polyserositis in weaned pigs.
6,7,8
  Mycoplasma 
hyosynoviae primarily colonizes tonsils of weaned pigs and may cause arthritis in 3- to 6-
month-old pigs.
6, 7, 9, 10, 11
  Despite a long history of research, specific information is lacking 
regarding the epidemiology and control of the diseases associated with these 
microorganisms.  At present, swine producers regard mycoplasma-associated arthritis as an 
increasing problem, impacting both animal well-being and the profitability of clinically-
affected populations.  Additionally, for the period 2003 to 2010, 17% of all arthritis cases 
diagnosed at the Iowa State University Veterinary Diagnostic Laboratory were attributed to 
M. hyorhinis and/or M. hyosynoviae.
12
 
Definitive diagnosis of mycoplasma-associated arthritis requires the isolation of the M. 
hyorhinis or M. hyosynoviae organism or detection of DNA in inflamed joint tissues.  For 
purposes of surveillance or field research, these microorganisms may also be detected in 
tonsil homogenates, lung tissues, and nasal swabs by culture or PCR procedures.
13, 14, 15
  
However, there is currently a lack of performance data on M. hyorhinis or M. hyosynoviae 
real-time polymerase chain reaction (RT-PCR) assays.  To address this need, we compared 
different DNA extraction protocols and various sample matrices (pen-based oral fluids, 
serum, nasal swab fluids, and tonsil scraping fluids) to determine the optimal combination for 
the detection of these pathogens.   
 
Materials and Methods 
Experimental Design 
Three methods of DNA extraction were evaluated by comparing the rate of detection of M. 
hyosynoviae or M. hyorhinis by RT-PCR in specimens (oral fluids, tonsil scraping fluids, 
nasal swab fluids, and serum) collected from 5 commercial finishing sites.  Extraction 
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protocols differed in sample volume, the volume of lysate used in the DNA extraction, final 
elution volume, and the method of DNA isolation (Table 1).   
 
Animals and Animal Care 
The study was performed at 5 commercial finisher sites that received pigs from one sow 
herd.  Each site had 2000 to 4000 18- to 24-week-old pigs in one or two barns.  Sites were 
selected based on proximity to the Iowa State University Veterinary Diagnostic Laboratory 
and a clinical history of mycoplasma-associated arthritis in previous groups of pigs received 
from the same sow herd, i.e., compatible histopathology and detection of M. hyosynoviae and 
M. hyorhinis by RT-PCR.  No vaccines against Mycoplasma spp. had been administered to 
the current group of pigs and no medications were in use at the time the experiment was 
conducted.  The experimental protocol was approved by the Iowa State University 
Institutional Animal Care and Use Committee (#7-11-7181-S). 
 
Sample Collection 
Sampling was carried out in one day on each of the 5 sites, with the objective of collecting 12 
pen-based oral fluids, blood samples from 30 pigs in the 12 pens, nasal swabs from 20 of the 
30 pigs, and tonsil (oropharyngeal) scrapings from 12 of the 20 nasal swab pigs.  Ultimately, 
a total of 340 biological specimens were collected, including 60 pen-based oral fluids, 150 
serum samples, 81 nasal swabs, and 49 tonsil scrapings.  Clinical specimen collection was 
performed seeking the optimal sample size but also considering resources availability 
sampling date.  
Within each site, oral fluids were collected using 5/8" cotton rope attached to a partition 
located in the middle of each pen.  The rope was cut to length so that the end was shoulder-
high to the animals.  Ropes were left in place for 20 to 25 minutes.  To recover the oral fluid 
specimen, the bottom (wet end) of each rope was inserted into a large plastic boot and the 
oral fluid was manually extracted by squeezing the rope.  The sample was decanted into a 50 
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ml disposable centrifuge tube for storage (Fisher Scientific Co., Pittsburgh, PA, USA).  At 
least 30 ml of oral fluid sample was collected from each pen.  Powder-free nitrile gloves 
were worn during the collection process and changed between each pen (Microflex 
Corporation, Drive Reno, NV).   
Pigs for individual sampling (blood, nasal swabs, and tonsil scrapings) were selected from 
the pens from which oral fluid specimens were collected.  Blood samples were collected 
using a single-use collection system (Vacuum tubes, BD, Franklin Lakes, NJ, USA).
 
 
Samples were centrifuged at 2000 x g for 10 minutes, after which serum was aliquotted into 
5 ml tubes and stored at -20ºC (BD Falcon™, BD Biosciences Discovery Labware, Two Oak 
Park, Bedford, MA, USA).   
Nasal swabs were collected from each naris and placed in 5 ml polystyrene round bottom 
snap-cap tubes
 
containing 2ml of 1X (PBS InvitrogenTM, Gibco, Grand Island, New York, 
USA).
 
 Tonsillar scrapings were collected by holding the mouth open with an oral speculum 
and scraping the surface of the tonsil using a sterilized, blunt stainless steel spoon with an 
elongated handle after restraining the animals with a nose snare.
16
  Tonsil scraping fluids 
were placed in 5 ml tubes containing 3 ml of sterile PBS 1X (previously tested negative for 
RT-PCR for both pathogens) and stored at -20 ºC until tested (BD Falcon™, BD Biosciences 
Discovery Labware, Two Oak Park, Bedford, MA, USA; InvitrogenTM, Gibco, Grand 
Island, New York, USA).   
 
Nucleic Acid Extraction and Real-Time Polymerase Chain Reaction (RT-PCR) 
Three methods of nucleic acid extraction were evaluated:  (1) High volume nucleic acid 
extraction using magnetic beads (HV) (MagMAX™ Viral RNA Isolation Kit, Applied 
Biosystems, Foster City, CA, USA); (2) Low volume nucleic acid extraction using magnetic 
beads (LV)
 (MagMAX™ Viral RNA Isolation Kit, Applied Biosystems, Foster City, CA, 
USA); and (3) spin column nucleic acid extraction (High Pure PCR Template Preparation 
Kit, Roche, Indianapolis, IN, USA).  
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High volume (HV) and low volume (LV) nucleic acid extraction using magnetic beads     HV 
and LV extraction protocols were based on a commercial kit and the samples were processed 
according to the manufacturer’s instructions.  The HV protocol used 300 μl of uncentrifuged 
pen-based oral fluids samples; the LV protocol used 50 μl of nasal swab fluid, tonsil scraping 
fluid, or serum.  After loading with samples, plates were placed onto a semi-automated 
nucleic acid purification system along with two plates each of washing solution 1 and 2, and 
a plate of elution buffer solution, as described by the manufacturer (KingFisher® 96 
magnetic particle processor, Thermo Fisher Scientific Inc., Waltham, MA, USA).  The HV 
protocol (oral fluid specimens) used the software program AM1836_DW_HV_v3; the LV 
protocol (nasal swab fluid, tonsil scraping fluid, and serum) used the program 
1836_DW_50_v3 (Applied Biosystems, Foster City, CA, USA).   Thereafter, the elution 
plate was sealed and frozen at - 20ºC until it was assayed by RT-PCR (AluminaSeal
TM
, 
Diversified Biotech, Dedham, MA, USA). 
Spin-column based nucleic acid extraction protocol (SC)     Protocol SC was based on a 
commercial kit and was performed as directed by the manufacturer (High Pure PCR 
Template Preparation Kit, Roche, Indianapolis, IN, USA).  A volume of 200 μl of 
uncentrifuged oral fluid, tonsil scraping fluid, nasal swab fluid, and serum was used for the 
reaction.  To elute the nucleic acid, 100 μl of pre-warmed (70ºC for 5 minutes) elution buffer 
was used.  Thereafter, all samples were then frozen at - 20ºC until assayed by RT-PCR. 
Real-time PCRs for M. hyorhinis and M. hyosynoviae    For this reaction, amplified products 
of M. hyosynoviae and M. hyorhinis were 397 and 161bp in length, respectively.  The 16s 
rRNA was the target sequence for both pathogens.  In brief, 22.5 μl of a solution composed 
of 12.5 μl of QuantiTect® SYBR® Green master mix (Qiagen® Inc., Valencia, CA, USA), 
one μl of 10 µM stock solution of reverse and forward primers for either M. hyosynoviae or 
M. hyorhinis, and 8 μl of nuclease-free water (Qiagen® Inc., Valencia, CA, USA) was 
pipetted into each well of a 96 well plate (Fast® PCR plates, Applied Biosystems, Foster 
City, CA, USA).  Mycoplasma hyosynoviae forward and reverse primers (Integrated DNA 
Technologies, Inc., San Diego, California) were: 5’- CAG TTG AGG AAA TGC AAC TGA 
AC -3’ and 5’- CGT CAG TGA TTG GCC ACC G -3’, respectively.  Mycoplasma hyorhinis 
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forward and reverse primers were: 5’- TGT TGA ACG GGA TGT AGC AA -3’ and 5’- 
TGA AGC TGT GAA GCT CCT TTC -3’, respectively.  DNA-extracted material (2.5 μl) 
was then added to each well.   
RT-PCR was then performed using a 96-well thermal cycler using the following cycling 
conditions: 1 cycle at 95ºC for 10 minutes, 45 cycles at 95ºC for 15 seconds, 59ºC for 30 sec 
(M. hyorhinis) or 63ºC for 30 sec (M. hyosynoviae), followed by a melting curve of 72ºC for 
30 sec, 95ºC for 15 sec, 60ºC for 1 min, and 95ºC for 15 seconds (7500 Fast Real-Time PCR 
System, Applied Biosystems, Foster City, CA, USA).  Quality controls included on each 
plate consisted of one well of previously DNA-extracted from nuclease-free water (negative 
control) and pure cultures of either M. hyorhinis or M. hyosynoviae (positive control).  
Analysis of amplification curves was performed using the manufacturer's software (7500 Fast 
Real-Time PCR System, Applied Biosystems, Foster City, CA, USA).  Auto baseline was 
used to determine fluorescence baselines, and the threshold was manually set at 0.04.  For 
either organism, a sample was considered positive if the Ct value was ≤ 44 and the melting 
temperature (Tm) was 75.7ºC ± 0.5ºC or 81.4ºC ± 0.5ºC, for M. hyorhinis and M. 
hyosynoviae, respectively.  RT-PCR reactions were done in duplicate.  In the case of 
discordant results, i.e., one positive and one negative, the sample was re-tested to achieve a 
consensus.   
 
Statistical Methods 
Statistical analysis was performed using commercial software SAS
®
 Version 9.2 (SAS® 
Version 9.2, SAS Institute Inc., Cary, NC, USA).  Differences in the detection of M. 
hyosynoviae and M. hyorhinis by DNA extraction protocol
l
 (high volume, low volume, spin 
column) were evaluated by sample type (OF, NS, TS) using Cochran’s Q test and 
McNemar's chi-square test.  Cochran's Q test was performed for each pathogen to detect 
differences in the detection rate among the four diagnostic tests.  Post-hoc pairwise 
comparisons between the binary diagnostic test results were done using McNemar's chi-
square test. 
24 
 
 
 
Results 
Overall, M. hyorhinis and M. hyosynoviae DNA were detected in all clinical specimens 
except for serum samples.  Depending on the extraction protocol, M. hyosynoviae DNA was 
detected in at least 58.3%, 9.9%, and 75.5% of pen-based oral fluids, nasal swab fluids, and 
tonsil scraping fluids, respectively (Table 2).  Mycoplasma hyorhinis DNA was detected in at 
least 70% of all pen-based oral fluids and in 96.3% and 97.9% of nasal swab fluids and tonsil 
scraping fluids, respectively (Table 2).  No statistically significant differences (P > 0.05) in 
the rate of detection were observed in comparisons of DNA extraction protocols by sample 
type for either M. hyosynoviae or M. hyorhinis, although differences in the absolute number 
of positives were observed for both sample type and extraction protocol (Table 2).  A 
comparison of tonsil vs. nasal swab nucleic acid detection rates revealed that a statistically 
higher proportion of tonsil scraping fluids were positive for M. hyosynoviae irrespective of 
the DNA extraction method (Table 3).  In contrast, M. hyorhinis DNA was detected in 97.9% 
of both nasal swab and tonsil scraping fluids, regardless of the DNA extraction protocol 
utilized.  An evaluation of extraction protocol (magnetic beads vs. spin column) across all 
sample types revealed a numeric difference in the results, with more positive results 
associated with spin column extraction (Table 4).  This difference was statistically significant 
for M. hyosynoviae (P = 0.0209), but not for M. hyorhinis (P = 0.1892). 
 
Discussion 
Mycoplasma hyosynoviae and M. hyorhinis can be isolated from the tonsil, nasal cavity, and 
synovial fluids of both experimentally-challenged and naturally-exposed animals using 
standard culture procedures.
 2, 10, 14, 17, 18, 19, 20  
However, laboratory culture of these slow-
growing organisms from clinical specimens is complicated by overgrowth of the bacteria 
invariably present in these samples.
21
  While the use of antibiotics may improve isolation by 
inhibiting the growth of competing microorganisms, recovery of mycoplasma species in the 
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diagnostic laboratory remains challenging.  As an alternative to culture, RT-PCR or 
enrichment followed by RT-PCR, promises a significant improvement in diagnostic 
performance, but this potential that can only be achieved through comparative studies that 
identify the optimum protocols and specimens.
22, 23
  Thus, the objective of the present study 
was to compare nucleic acid extraction protocols and specific sample matrices, i.e., serum, 
tonsil scraping fluids, nasal swab fluids, and pen-based oral fluids, in order to identify the 
optimal diagnostic protocol for the detection of these pathogens.   
Mycoplasma hyosynoviae has been cultured from the blood of infected pigs
9, 20
, but all serum 
samples were negative for both M. hyosynoviae and M. hyorhinis in this study potentially 
indicating the true absence of bacteremia due to lack of clinical signs in the population at that 
point in time or a low sensitivity provided by this sample type.  In contrast, both M. 
hyosynoviae and M. hyorhinis DNA were detected in tonsil scraping fluids, nasal swab fluids, 
and pen-based oral fluids.  Mycoplasma hyosynoviae was more commonly detected in tonsil 
scraping vs. nasal swab fluids (Table 3), whereas M. hyorhinis was detected in both nasal 
swab and tonsil scraping fluids.  These results may reflect either the stage of infection or 
possible differences in tissue tropism (tonsil vs. nasal cavity); however, this hypothesis 
would have to be appropriately investigated under experimental condition.  While previous 
research has demonstrated that a variety of pathogens may be detected in porcine oral fluids, 
e.g., influenza virus, Actinobacillus pleuropneumoniae, Erysipelothrix rhusiopathiae, porcine 
respiratory and reproductive syndrome virus (PRRSV), Porcine circovirus type 2, and 
others
24-30
, this study confirmed that M. hyosynoviae and M. hyorhinis may also be detected 
by RT-PCR in pen-based oral fluids samples.   
Comparisons have shown significant differences among nucleic acid extraction protocols in 
the rate of PRRSV detection in oral fluids.
31
  No statistically significant differences in 
detection rates were detected when comparing DNA extraction protocols within each of the 
three sample types, but a higher proportion of positive samples were uniformly observed with 
the spin column DNA extraction protocol for all sample types (Table 2).  Collapsing the data 
and comparing the detection rate across all sample types revealed a statistically significant 
difference in the proportion of M. hyosynoviae-positive samples detected with spin column 
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vs. magnetic bead extraction.  No significant difference existed for M. hyorhinis-positive 
samples.   
Overall, this study provided guidelines for the detection of M. hyosynoviae and M. hyorhinis 
in clinical specimens submitted to the diagnostic laboratory.  More specifically, these data 
suggest that tonsil scraping fluid is preferable to nasal swab fluid for screening individual 
animals, and oral fluids may be useful for population surveillance.  Furthermore, the data 
suggest that spin column DNA extraction may provide better diagnostic sensitivity, but it 
should be recognized that molecular diagnostics are in a period of rapid evolution.  
Therefore, future comparative studies will be required.   
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Implications 
1. Mycoplasma hyosynoviae and M. hyorhinis could be detected in nasal swabs, oral fluids 
and tonsillar scrapings regardless of the DNA extraction protocol utilized. 
2. Tonsillar scrapings are preferable to nasal swab fluid for screening individual animals for 
either pathogen, although M. hyorhinis was successfully detected in nasal swabs.  
3. The presence of these organisms in oral fluids opens a new opportunity for understanding 
the dynamic of infection in endemic herds; although, improvements may be necessary to 
maximize the assay performance. 
4. Detection of these pathogens in pig populations should be combined with clinical data in 
future studies to better understand the usefulness of these new diagnostics tools and 
routinely used sample methods. 
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Table 1.  Comparison of Mycoplasma hyosynoviae and Mycoplasma hyorhinis DNA 
extraction protocols by sample type   
 
Extraction 
Protocol 
Sample type
*
 
Sample 
volume 
Lysis 
solution 
Elution 
buffer 
DNA capture 
High volume OF 300 μl 450 μl 90 μl Magnetic bead 
Low volume S, NS, TS 50 μl 130 μl 50 μl Magnetic bead 
Spin column OF, S, NS, TS 200 μl 200 μl 100 μl Silica gel 
 
* 
OF (oral fluid), S (serum), NS (nasal swab fluid), and TS (tonsil scraping fluid) collected 
from pigs in commercial production systems  
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Table 2.  Summary of RT-PCR-positives (%) by sample type, and extraction protocol 
 
 
*
 Oral fluid (OF), nasal swab fluid (NS), and tonsil scraping fluid (TS) 
† 
Number and proportion of positive samples 
‡
 Comparisons between extraction protocols by sample type (McNemar's chi-square test) 
 
 
Sample type
* 
Extraction protocol
†
 
Diagnostic 
agreement 
P value
‡
 
High volume Low volume Spin column 
M. hyosynoviae      
   OF (n = 60) 35 (58.3%) 
Not 
applicable 
39 (65.0%) 83% 0.34 
   NS (n = 81) 
Not 
applicable 
8 (9.9%) 12 (14.8%) 89% 0.29 
   TS (n = 49) 
Not 
applicable 
37 (75.5%) 42 (85.7%) 92% 0.18 
M. hyorhinis      
   OF (n = 60) 42 (70.0%) 
Not 
applicable 
49 (81.7%) 75% 0.12 
   NS (n = 81) 
Not 
applicable 
78 (96.3%) 79 (96.3%) 95% 1.00 
   TS (n = 49) 
Not 
applicable 
48 (97.9%) 48 (97.9%) 96% 1.00 
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Table 3.  Pairwise comparison* of the detection rate of Mycoplasma hyosynoviae nucleic 
acid by sample type and DNA extraction protocol 
 
Sample type and DNA extraction 
protocol (number of RT-PCR 
positive results) 
TSMB 
(n = 37
†
) 
NSMB 
(n = 6) 
TSSC 
(n = 42) 
NSSC 
(n = 7) 
TSMB - Tonsil scraping fluid 
extracted using low volume-
magnetic beads protocol (n = 37) 
NA 
P < 
0.0001 
P = 
0.0956 
P < 
0.0001 
NSMB - Nasal swab fluid 
extracted using low volume-
magnetic beads protocol (n = 6) 
P < 
0.0001 
NA 
P < 
0.0001 
P = 
0.5637 
TSSC - Tonsil scraping fluid 
extracted using spin column 
protocol (n = 42) 
P = 
0.0956 
P < 
0.0001 
NA 
P < 
0.0001 
NSSC - Nasal swab fluid extracted 
using spin column protocol (n = 7) 
P < 
0.0001 
P = 
0.5637 
P < 
0.0001 
NA 
 
* 
P values calculated using McNemar’s chi-square test.  
† 
Number of RT-PCR positive samples among 49 samples tested 
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Table 4.  Pairwise comparison of the detection rate of Mycoplasma hyosynoviae and 
Mycoplasma hyorhinis by DNA extraction protocol across all sample types* 
 
 
 
 
 
 
 
*
 Oral fluid (n = 60), nasal swab fluid (n = 81), and tonsil scraping fluid (n = 49), as given in 
Table 1. 
†
 Includes both high- and low-volume magnetic bead extraction protocols 
‡
 Comparisons between extraction protocols by pathogen (McNemar's chi-square test) 
§
 Number and proportion of positive samples 
 
 
 
  
Mycoplasma spp.
 
Extraction protocol  
Magnetic beads
†
 Spin column P value
‡
 
M. hyosynoviae 80 (42.1%)
§
 93 (48.9%) 0.0209 
M. hyorhinis 168 (88.4%) 175 (92.1%) 0.1892 
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CHAPTER 3.  LONGITUDINAL INVESTIGATION OF MYCOPLASMA 
HYOSYNOVIAE AND MYCOPLASMA HYORHINIS INFECTIONS IN A WEAN-TO-
FINISH POPULATION 
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Abstract 
Given the limited epidemiological information available on Mycoplasma hyosynoviae and M. 
hyorhinis infections, the objective of this longitudinal study was to describe the circulation of 
these pathogens in a commercial wean-to-finish swine population.  Pigs in a wean-to-finish 
barn housing 2,420 animals (220 pigs per pen) were monitored for M. hyorhinis and M. 
hyosynoviae infections using serum and pen-based oral fluid samples collected at placement 
and each ~30 days thereafter.  Diagnostic results were evaluated as the proportion of real-
time polymerase chain reaction (RT-PCR) positive oral fluid samples and changes in mean 
serum antibody ELISA optical density (OD) response over time.  M. hyorhinis RT-PCR-
positive oral fluid specimens were detected at 28 days post placement (DPP), whereas M. 
hyosynoviae was not detected until 88 DPP.  Thereafter, all pen-based oral fluid samples 
were RT-PCR positive for both organisms through 148 DPP.  Mean serum antibody ELISA 
OD responses reflected RT-PCR results for both organisms.  M. hyorhinis OD values 
declined significantly (P < 0.05) after 0 DPP and then increased significantly at each 
sampling point thereafter, reaching a plateau at 88 DPP.  The pattern was similar for M. 
hyosynoviae OD values, although the timing was somewhat delayed compared to M. 
hyorhinis.  Overall, distinctly different patterns of shedding were demonstrated for each 
mycoplasma in this population, but the patterns of circulation were consistent with previous 
reports.  The combination of specimen types and diagnostic assays could be used to in the 
future to explore the dynamics of mycoplasmal infections in endemically-infected swine 
populations. 
Key-words: Swine, Mycoplasma hyorhinis, Mycoplasma hyosynoviae, ELISA, real time- 
PCR 
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Introduction 
Mycoplasma hyosynoviae and M. hyorhinis infections are common in swine populations, 
with pigs becoming infected by contact with sows or older pigs in the system (Hagerdon-
Olsen et al., 1999; Ross et al., 1973; Thacker and Minion, 2012).  Pigs are believed to 
become infected with M. hyosynoviae in the early growing phase (8 to 12 weeks), while M. 
hyorhinis is more likely to be found in pigs immediately after weaning (Clavijo et al., 2012, 
Kobisch et al., 1996, Nielsen et al., 2001, Thacker and Minion, 2012).  Primary replication 
occurs in the upper respiratory tract, followed by dissemination to other tissues (Thacker and 
Minion, 2012).  Given the limited epidemiological information available, the objective of this 
longitudinal study was to describe the circulation of these pathogens in a commercial wean-
to-finish swine population.   
 
Materials and Methods 
Experimental Design 
Pigs in a wean-to-finish barn housing 2,420 animals (220 pigs per pen) were monitored for 
148 days post placement (DPP) for evidence of exposure to M. hyorhinis and M. 
hyosynoviae.  Samples collected at placement and approximately every 30 days thereafter 
were tested using a Tween 20 antibody ELISA (serum) and real-time polymerase chain 
reaction (RT-PCR) (pen-based oral fluids) for evidence of M. hyorhinis and M. hyosynoviae 
infections.  Results were evaluated as changes in antibody response (optical density) and the 
proportion of RT-PCR positive samples over time. 
 
Animals and Animal Care 
The study was performed in one wean-to-finish barn with pigs placed at approximately 3 
weeks of age.  The barn housed a total of 2420 animals in 11 pens, i.e., 220 animals per pen.  
The production site was selected based on its clinical history.  That is, both the sow herd 
from which the pigs were sourced and previous groups of pigs sourced from the sow herd 
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had a history of mycoplasma-associated arthritis.  No vaccines or specific treatments against 
either M. hyosynoviae or M. hyorhinis were used during the observation period and animal 
care and management protocols were consistent with previous batches.  The experimental 
protocol was approved by the Iowa State University Institutional Animal Care and Use 
Committee. 
 
Sample Collection 
At placement, 5 pens evenly distributed throughout the barn were selected for longitudinal 
sampling and 6 pigs from each pen were ear-tagged for identification.  Thereafter, pen-based 
oral fluids and blood samples were collected by caretakers and the herd veterinarian at 6 time 
points from placement through 150 DPP, i.e., 0, 28, 58, 88, 118, and 148 DPP.   
Blood samples were collected using a single-use collection system (BD Vacutainer®, BD 
Diagnostics, Franklin Lakes, NJ, USA), centrifuged at 2000 x g for 10 minutes, and the 
harvested serum stored at -20°C until tested.   
Pen-based oral fluids were collected using cotton rope (5/8 inches or 1.59 cm) attached to a 
partition located in the middle of each pen, as described elsewhere (Prickett et al., 2008).  
The rope was cut such that the end was at shoulder level to the pigs in the pen.  Ropes were 
left in place for 20 to 25 minutes, during which time the pigs chewed the rope, depositing 
oral fluids in the process.  To recover the oral fluid, the bottom (wet) portion of each rope (10 
to 12 inches) was inserted into a disposable plastic boot and the oral fluids extracted by 
manually squeezing the rope.  The fluid recovered in the bag (~30 ml) was decanted into 
tubes and stored at -20°C until tested.  Nitrile gloves (Microflex Corporation, Drive Reno, 
NV) were used throughout the collection process and were changed between each pen.  
 
Nucleic Acid Extraction and Real-Time Polymerase Chain Reaction (RT-PCR) 
High volume nucleic acid extraction using magnetic beads     The extraction protocol was 
based on a commercial kit (MagMAX™ Viral RNA Isolation Kit, Applied Biosystems, 
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Foster City, CA, USA) and the samples were processed according to the manufacturer’s 
instructions.  In brief, after loading the plates with 300 μl of unprocessed pen-based oral 
fluids samples, plates were placed onto a semi-automated nucleic acid purification system 
(KingFisher® 96 magnetic particle processor, Thermo Fisher Scientific Inc., Waltham, MA, 
USA) along with 2 plates of washing solution 1, 2 plates of washing solution 2, and one plate 
of elution buffer solution, as described by the manufacturer.  The software program used was 
AM1836_DW_HV_v3 (Applied Biosystems, Foster City, CA, USA).  Thereafter, the elution 
plate was sealed (AluminaSeal
TM
, Diversified Biotech, Dedham, MA, USA) and frozen at - 
20ºC until it was assayed by RT-PCR. 
Real-time PCRs for M. hyorhinis and M. hyosynoviae    In brief, 22.5 μl of a solution 
composed of 12.5 μl of QuantiTect® SYBR® Green master mix (Qiagen® Inc., Valencia, 
CA, USA), one μl of 10 µM stock solution of reverse and forward primers (Integrated DNA 
Technologies, Inc., San Diego, California) for either M. hyosynoviae or M. hyorhinis, and 8 
μl of nuclease-free water (Qiagen® Inc., Valencia, CA, USA) was pipetted into each well of 
a 96-well plate (Fast® PCR plates, Applied Biosystems, Foster City, CA, USA).  M. 
hyosynoviae forward and reverse primers were: 5’- CAG TTG AGG AAA TGC AAC TGA 
AC -3’ and 5’- CGT CAG TGA TTG GCC ACC G -3’, respectively.  M. hyorhinis forward 
and reverse primers were: 5’- TGT TGA ACG GGA TGT AGC AA -3’ and 5’- TGA AGC 
TGT GAA GCT CCT TTC -3’, respectively.  DNA-extracted material (2.5 μl) was then 
added to each well.  For this reaction, amplified products of M. hyosynoviae and M. hyorhinis 
were 397 and 161bp in length, respectively.  RT-PCR assays targeted the 16S rRNA 
sequence of either pathogen. 
RT-PCR was performed using a 96-well thermal cycler (7500 Fast Real-Time PCR System, 
Applied Biosystems, Foster City, CA, USA) using the following cycling conditions: one 
cycle at 95ºC for 10 minutes, 45 cycles at 95ºC for 15 seconds, 59ºC for 30 sec (M. 
hyorhinis) or 63ºC for 30 sec (M. hyosynoviae), followed by a melting curve of 72ºC for 30 
sec, 95ºC for 15 sec, 60ºC for 1 min, and 95ºC for 15 seconds.  Quality controls included on 
each plate consisted of one well of previously DNA-extracted nuclease-free water (negative 
control) and a pure culture of either M. hyorhinis or M. hyosynoviae (positive control).  
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Analysis of amplification curves was performed using the manufacturer's software (7500 Fast 
Real-Time PCR System, Applied Biosystems, Foster City, CA, USA).  Auto baseline was 
used to determine fluorescence baselines, and the threshold was manually set at 0.04.  For 
either organism, a sample was considered positive if the Ct value was ≤ 44 and the melting 
temperature (Tm) was 75.7ºC ± 0.5ºC or 81.4ºC ± 0.5ºC, for M. hyorhinis and M. 
hyosynoviae, respectively.  RT-PCR reactions were done in duplicate.  In the case of 
discordant results, i.e., one positive and one negative, the sample was re-tested to achieve a 
consensus.   
 
Enzyme-Linked Immunosorbent Assay (ELISA) 
Serum samples were tested in duplicate for the presence of antibodies against M. hyosynoviae 
and M. hyorhinis using an adaptation of a Tween 20 assay previously described for M. 
hyopneumoniae (Bereiter et al., 1990).  In brief, the antigens for the ELISAs were extracted 
from whole-cell cultures of M. hyorhinis and M. hyosynoviae using a Tween 20 detergent 
reagent.  Plates were individually prepared for each organism.  Wells of 96-well plates (Nunc 
Immulon 2 HB, Thermo Fisher Scientific Inc., Waltham, MA, USA) were coated with 100 μl 
of 10 μg per ml of each antigen in carbonate-bicarbonate buffer (pH 9.6).  Thereafter, plates 
were incubated overnight at room temperature and then stored at -80ºC.   
To perform the assay, plates were thawed and the wells hand-washed 3 times with 200 µl of 
wash solution composed of 0.85% NaCl (Fisher Scientific Co., Pittsburgh, PA, USA) and 
0.05% Tween® 20 (Sigma-Aldrich® Co. LLC, Saint Louis, MO, USA).  Thereafter, 100 μl 
of serum diluted 1:50 in Tris buffered saline (Tris HCl (THAM) H2NC(CH2OH)3, Fisher 
Scientific Co., Pittsburgh, PA, USA) was added to each well, the plates incubated at 37ºC for 
30 minutes, and then the plates were washed 3 times with wash solution.  One positive and 
one negative control, i.e., serum from animals of known status, were run on each plate as 
quality controls.  To detect reactions, 100 μl of a 1:10,000 dilution of peroxidase-conjugated 
rabbit anti-pig IgG (ICN Biomedicals, Irvine, CA, USA) was dispensed into each well, after 
which the plates were incubated for 30 minutes at 37ºC and then washed 3 times.  TMB 
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substrate-chromogen (100 μl) (TMB One-Step Substrate System, Dako North America Inc., 
Carpinteria, CA, USA) was added to each well, plates were incubated for an additional 8 
minutes at 37°C, and then 100 μl of stop solution (PRV gI Antibody Test, Idexx 
Laboratories, Westbrook, ME, USA) was dispensed into each well.  Plates were read at 405 
nm (Model AL310, Bio-Tek instruments, Inc., Winooski, VT, USA) and the results given as 
optical density (OD).  For each plate, sample results were adjusted by subtracting the OD of 
the negative control.   
 
Statistical Methods 
Statistical analysis of the data was performed using the MedCalc® Version 12.2.1.0 
(Broekstraat 52, 9030 Mariakerke, Belgium).  Pen-based oral fluid RT-PCR data and 
individual pig serum ELISA OD results were grouped by (DPP).  Initially, summary statistics 
were calculated for all groups to assess the overall quality of the data including normality.  
Repeated measure analysis of variance (ANOVA) was then used to evaluate serum OD 
values for quantitative differences in response among groups over time.  Values of P <0.05 
were defined as statistically significant.  
 
Results 
Testing of pen-based oral fluids by RT-PCR revealed distinctly different patterns of 
circulation (M. hyorhinis vs. M. hyosynoviae) in the monitored population.  M. hyorhinis RT-
PCR-positive oral fluid specimens were detected in samples on day 28 DPP, whereas M. 
hyosynoviae was not detected until 88 DPP (Figures 1 and 2).  Thereafter, all tested samples 
were positive for both organisms through 148 DPP.  Mean serum ELISA OD values reflected 
RT-PCR results for both organisms.  As shown in Figure 1, M. hyorhinis OD values declined 
significantly (P < 0.05) after 0 DPP and then increased significantly at each sampling point 
thereafter, reaching a plateau at 88 DPP.  As shown in Figure 2, the pattern was similar for 
M. hyosynoviae, although the timing was somewhat delayed compared to M. hyorhinis. 
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Discussion 
Mycoplasma-associated arthritis is increasingly recognized for its impact on both animal 
well-being and the productivity of clinically-affected populations.  As an example of this 
trend, 17% of all arthritis cases diagnosed at the Iowa State University Veterinary Diagnostic 
Laboratory from 2003 to 2010 were attributed to M. hyorhinis and/or M. hyosynoviae 
(Gomes Neto et al., 2012).  Even so, interpretation of the apparent changes in the 
presentation and/or clinical importance of these pathogens is compromised by a lack of 
information describing their epidemiology in the field.  Different patterns of M. hyosynoviae 
infection have been reported in naturally-exposed populations.  In the course of investigating 
three herds, Hagerdon-Olsen et al. (1999) found that infection was limited to adult animals in 
one herd, but occurred in all stages of production in two herds; both with and without 
antibody production and in the presence or absence of clinical arthritis.  There is even less 
descriptive epidemiology available on M. hyorhinis infection.  Essentially, our current 
knowledge is based on data from Veterinary Diagnostic Laboratories or prevalence studies 
based on specimens collected at slaughter (Falk et al., 1991, Gomes Neto et al., 2012, 
Makhanon et al., 2011, Palzer et al., 2008, Schulman et al., 1970). 
The objective of this longitudinal study was to describe the circulation of these pathogens in 
a commercial wean-to-finish swine population via collection and testing of both serum and 
pen-based oral fluid specimens.  Serum antibodies were used to indirectly follow the course 
of the infection and monitor the development of humoral immunity in the herd.  The use of 
oral fluid samples was justified by the fact that both M. hyosynoviae and M. hyorhinis are 
commonly detected in tonsils of infected animals (Clavijo et al., 2012, Hagedorn-Olsen et al., 
1999, Kobisch et al., 1996, Ross et al., 1973, Thacker and Minion, 2012).  This approach was 
also supported by the work that has been done with other pathogens, e.g., Haemophilus 
parasuis, Streptococcus suis, Actinobacillus pleuropneumoniae, Erysipelothrix 
rhusiopathiae, swine influenza, porcine circovirus type 2, porcine respiratory and 
reproductive syndrome virus, and others (Bender et al., 2010, Costa et al., 2012, Prickett et 
al., 2010, Ramirez et al., 2012).   
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Although the detection of serum antibody against M. hyosynoviae or M. hyorhinis has not 
been proven to correlate with the disease status of individual animals, it may useful for 
evaluating exposure and/or vaccine compliance at the population level (Hagedorn-Olsen et 
al., 1999, Nielsen et al., 2005).  A variety of assays have been used to detect antibodies 
against M. hyosynoviae and M. hyorhinis, e.g., the metabolic inhibition test, indirect 
hemagglutination, complement fixation, and latex-agglutination (Freeman et al., 1984, Ross 
et al., 1972, Zimmerman et al., 1977, Zimmerman et al., 1982).  In addition, a Tween 20 
ELISA assay has long been used for the detection of antibodies against M. hyopneumoniae; 
thus, suggesting its possible application for other swine mycoplasmas (Bereiter et al., 1990).   
In this study, a decline in the mean M. hyorhinis and M. hyosynoviae OD values post 
weaning was suggestive of decaying maternal immunity; with the subsequent increase in 
serum antibody indicative of extensive spreading and an adaptive immune response (Figures 
1 and 2).  This interpretation of the serological response was supported by RT-PCR testing of 
pen-based oral fluids.  Although no RT-PCR positive samples were detected at placement, 
the majority of samples were positive from 28 DPP to the end of the observation period at 
148 DPP (Figure 1).  In contrast, oral fluid specimens were negative for M. hyosynoviae until 
88 DPP, after which most samples were positive through 148 DPP (Figure 2).  Within this 
population, distinctly different patterns of shedding were demonstrated for each 
microorganisms using RT-PCR testing of pen-based oral fluid samples, but the patterns of 
circulation were consistent with previous reports (Clavijo et l., 2012, Hagerdon-Olsen et al., 
1999).   
Despite evidence of extensive transmission and infection, no overt clinical effects attributable 
to either M. hyorhinis or M. hyosynoviae were observed.  These observations leave large 
questions concerning the role of maternal and protective immunity in the control of the 
infection unanswered, but demonstrate that further field studies could be conducted using this 
approach.  Regardless, the current study demonstrates that a combination of multiple samples 
types and diagnostic assays may provide insight into the dynamics of mycoplasmal infections 
in endemically-infected swine populations.  
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Implications 
●  Real-time PCRs for M. hyorhinis and M. hyosynoviae can be used with pen-based oral 
fluids to understand the circulation of these pathogens. 
● The use of either M. hyosynoviae or M. hyorhinis Tween 20 ELISA assays can contribute 
to an understanding of the role of maternal and/or adaptive humoral immunity in infected 
populations. 
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Figure 1. ELISA antibody response (left y-axis-gray line) against M. hyorhinis in pigs 
through 148 DPP.  Values are reported as group mean O.D. ± S.E.M. (*asterisks 
represent time-points with statistically significant difference in mean OD values).  
Proportion of RT-PCR positive pen-based oral fluids (right y-axis-blue bars). 
a,b,c,d 
Mean OD values without a common superscript differ (P <0.05). 
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Figure 2. ELISA antibody response (left y-axis-red line) against M. hyosynoviae in pigs 
through 148 DPP.  Values are reported as group mean O.D. ± S.E.M. (* asterisks 
represent time-points with statistically significant difference in mean OD values).  
Proportion of RT-PCR positive pen-based oral fluids (right y-axis-gray bars). 
a,b,c 
Mean OD values without a common superscript differ (P <0.05). 
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GENERAL CONCLUSIONS 
Advances in swine medicine have unquestionably changed the views and attitudes of 
producers, practitioners, and researchers on how to produce meat in a socially responsible, 
welfare friendly, and economically sustainable manner.  Surveillance and control of 
emerging and re-emerging diseases by national and international institutions is part of this 
equation. In this context, mycoplasma-associated arthritis may be regarded as a re-emergent 
issue with important economic and welfare implications.  That is, animals affected by 
mycoplasma-associated arthritis require treatment or humane euthanasia.  Preferable to either 
of these courses is prevention of mycoplasmal diseases through prophylactic approaches.  
Therefore, the objective of this thesis was to explore new diagnostic approaches to be used to 
better understand the diagnostics and epidemiology of Mycoplasma hyosynoviae and M. 
hyorhinis.   
Molecular diagnostic techniques have been rapidly implemented in veterinary diagnostic 
laboratories.  However, these tools cannot be used effectively until they have been validated 
for each pathogen and diagnostic specimen.  A major purpose of the research described 
within this thesis was to investigate the applicability of real-time PCR to the detection of M. 
hyosynoviae and M. hyorhinis in specimen types routinely submitted to veterinary diagnostic 
laboratories.  Interestingly, both M. hyosynoviae and M. hyorhinis were detected in pen-based 
oral fluids samples.  Likewise, tonsil scraping samples were also highly effective at detecting 
these pathogens in individual pigs.  Subsequently, these diagnostic tools - in tandem with 
serum ELISAs - were used to monitor the circulation of these pathogens in a wean-to-finish 
population over time.  In this particular population, distinct patterns of infection were 
demonstrated for each microorganism.   
Overall, this work demonstrated the practical applications of these new technologies to field 
and diagnostic situations.  However, we are also left with challenging questions concerning 
the epidemiology, pathogenesis, and diagnosis of M. hyosynoviae and M. hyorhinis. For 
example, many herds infected with M. hyosynoviae or M. hyorhinis never present evidence of 
clinical disease, despite the chronic presence of these mycoplasmas in pen-based oral fluids, 
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nasal swabs fluids, or tonsil scrapings.  Why are some pigs clinically affected by these 
infections and the majority are not?  At this juncture, we have little understanding of the role 
of mycoplasmal genetic evolution or virulence factors in the expression of disease.  
Likewise, pig genetics have resulted in a highly productive phenotype, but whether host 
tolerance or susceptibility to these agents has been affected in this process is unknown.  For 
the immediate future, there is a clear need to commit resources toward elucidating the 
clinical and economic impact of mycoplasma-associated arthritis in the contemporary swine 
industry.  For the long term solution, the core question revolves around the mechanisms of 
pathogenesis and the triggers of clinical disease.  The good news is that, in spite of these 
lingering unknowns, we are better equipped than ever before to diagnose M. hyosynoviae and 
M. hyorhinis in the diagnostic laboratory and conduct studies in the field.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
 
ACKNOWLEDGEMENTS 
I would like to thank the faculty and staff from the departments of Veterinary Diagnostic and 
Production Animal Medicine, Veterinary Microbiology and Preventive Medicine, and the 
Iowa State University Veterinary Diagnostic Laboratory for their contributions and support.  
Also, I extend special thanks to the members of my committee, especially to my advisor Dr. 
Erin Strait for her mentorship and support.  I am convinced that this experience has made me 
a wiser person and will continue to benefit me far into the future.  I completely agree with the 
saying, “Tudo vem com um preço, mas é prazeroso no final.”  This has been my story at 
Iowa State and I am very thankful.    
 
